source
- FDA Commissioner Marty Makary Resigns After Turbulent TenureMarty Makary stepped down as commissioner of the U.S. Food and Drug Administration on Tuesday, ending a period marked by controversy and intense scrutiny. His resignation follows a series of publi…
- Mid-size pharma firms drive surge in biopharma M&A activityThe article notes that 2026 is shaping up as one of the busiest years for biopharma mergers and acquisitions on record. Unlike previous years dominated by large multinational companies, a broader…